These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 8977758

  • 1. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 2. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH.
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [Abstract] [Full Text] [Related]

  • 3. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
    Stiefel P, García-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A.
    Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP.
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K, Remer T, Fritsche A, Häring HU, Maser-Gluth C.
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
    [Abstract] [Full Text] [Related]

  • 9. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
    Ferrari P, Sansonnens A, Dick B, Frey FJ.
    Hypertension; 2001 Dec 01; 38(6):1330-6. PubMed ID: 11751713
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids.
    Główka FK, Kosicka K, Karaźniewicz-Łada M.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb 01; 878(3-4):283-9. PubMed ID: 20018571
    [Abstract] [Full Text] [Related]

  • 12. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN, Riemens SC, Sluiter WJ, Pratt JJ, Wolthers BG, Dullaart RP.
    Clin Endocrinol (Oxf); 2000 Apr 01; 52(4):403-11. PubMed ID: 10762282
    [Abstract] [Full Text] [Related]

  • 13. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A, Takasaka T, Shibasaki H, Kasuya Y, Kawashima S, Yamada A, Furuta T.
    Steroids; 2012 Oct 01; 77(12):1291-7. PubMed ID: 22850318
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men.
    Kerstens MN, van der Kleij FG, Boonstra AH, Sluiter WJ, van der Molen JC, Navis G, Dullaart RP.
    Kidney Int; 2004 Jun 01; 65(6):2065-70. PubMed ID: 15149319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M, Zehnder D, Lepenies J, Petrelli MD, Moore JS, Hughes SV, Cockwell P, Hewison M, Stewart PM.
    Eur J Endocrinol; 2005 Aug 01; 153(2):291-9. PubMed ID: 16061836
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice.
    Ceccato F, Antonelli G, Barbot M, Zilio M, Mazzai L, Gatti R, Zaninotto M, Mantero F, Boscaro M, Plebani M, Scaroni C.
    Eur J Endocrinol; 2014 Jul 01; 171(1):1-7. PubMed ID: 24743401
    [Abstract] [Full Text] [Related]

  • 19. [Effects of activity of 11β-hydroxysteroid dehydrogenase type 2 on serum potassium levels in Cushing's syndrome patients].
    Lian P, Li H, Zhang Y, Ji Z.
    Zhonghua Yi Xue Za Zhi; 2015 Mar 31; 95(12):929-32. PubMed ID: 26081057
    [Abstract] [Full Text] [Related]

  • 20. [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome].
    Stiefel P, Jiménez L, García-Morillo JS, Leal A, Villar J, Carneado J.
    Med Clin (Barc); 2000 Jun 17; 115(3):90-2. PubMed ID: 10965482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.